L’Oreal Falls Short On Safety, Efficacy, Adverse Event Data
This article was originally published in The Tan Sheet
Executive Summary
FDA says it needs additional data from L’Oreal on safety, efficacy and adverse events to determine GRASE for drometrizole trisiloxane.